Condition
Mesothelioma, Malignant
Estimated Enrollment: 20
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Observational
Study Design Allocation: Time Perspective: Prospective
Study ID Numbers: 1287
Study First Received: June 26, 2015
Last Updated: November 18, 2016
Estimated Primary Completion Date: September 2017
Primary Outcome Measures:
Variation of SUVmax (Maximal Standardized Uptake Value) in patients undergoing talc pleurodesis
Sponsors and Collaborators:
Istituto Clinico Humanitas
Website Link: https://ClinicalTrials.gov/show/NCT02519049
